Stefanski A - Search Results

1

Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure in Adults With Body Mass Index ≥27 kg/m²: SURMOUNT-1 Ambulatory Blood Pressure Monitoring Substudy.

de Lemos JA, Linetzky B, le Roux CW, Laffin LJ, Vongpatanasin W, Fan L, Hemmingway A, Ahmad NN, Bunck MC, Stefanski A. de Lemos JA, et al. Among authors: stefanski a. Hypertension. 2024 Apr;81(4):e41-e43. doi: 10.1161/HYPERTENSIONAHA.123.22022. Epub 2024 Feb 5. Hypertension. 2024. PMID: 38314555 Free PMC article. No abstract available.

2

Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison.

le Roux CW, Hankosky ER, Wang D, Malik R, Yu M, Hickey A, Kan H, Bunck MC, Stefanski A, Garcia-Perez LE, Wharton S. le Roux CW, et al. Among authors: stefanski a. Diabetes Obes Metab. 2023 Sep;25(9):2626-2633. doi: 10.1111/dom.15148. Epub 2023 Jun 21. Diabetes Obes Metab. 2023. PMID: 37344384

3

Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT-1 trial.

Hankosky ER, Wang H, Neff LM, Kan H, Wang F, Ahmad NN, Stefanski A, Garvey WT. Hankosky ER, et al. Among authors: stefanski a. Diabetes Obes Metab. 2023 Dec;25(12):3748-3756. doi: 10.1111/dom.15269. Epub 2023 Sep 12. Diabetes Obes Metab. 2023. PMID: 37700443 Clinical Trial.

4

Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysis.

Hankosky ER, Wang H, Neff LM, Kan H, Wang F, Ahmad NN, Griffin R, Stefanski A, Garvey WT. Hankosky ER, et al. Among authors: stefanski a. Diabetes Obes Metab. 2024 Jan;26(1):319-328. doi: 10.1111/dom.15318. Epub 2023 Nov 6. Diabetes Obes Metab. 2024. PMID: 37932236 Clinical Trial.

5

Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial.

Krumholz HM, de Lemos JA, Sattar N, Linetzky B, Sharma P, Mast CJ, Ahmad NN, Bunck MC, Stefanski A. Krumholz HM, et al. Among authors: stefanski a. Heart. 2024 Sep 16;110(19):1165-1171. doi: 10.1136/heartjnl-2024-324170. Heart. 2024. PMID: 39084707 Free PMC article. Clinical Trial.

6

Generalized Stomatal Optimization of Evolutionary Fitness Proxies for Predicting Plant Gas Exchange Under Drought, Heatwaves, and Elevated CO₂.

Potkay A, Cabon A, Peters RL, Fonti P, Sapes G, Sala A, Stefanski A, Butler E, Bermudez R, Montgomery R, Reich PB, Feng X. Potkay A, et al. Among authors: stefanski a. Glob Chang Biol. 2025 Jan;31(1):e70049. doi: 10.1111/gcb.70049. Glob Chang Biol. 2025. PMID: 39873117 Free PMC article.

7

Time to weight plateau with tirzepatide treatment in the SURMOUNT-1 and SURMOUNT-4 clinical trials.

Horn DB, Kahan S, Batterham RL, Cao D, Lee CJ, Murphy M, Gonsahn-Bollie S, Chigutsa F, Stefanski A, Dunn JP. Horn DB, et al. Among authors: stefanski a. Clin Obes. 2025 Jan 12:e12734. doi: 10.1111/cob.12734. Online ahead of print. Clin Obes. 2025. PMID: 39800653

8

Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT-1 to -4 trials.

Rubino DM, Pedersen SD, Connery L, Cao D, Chigutsa F, Stefanski A, Fraseur Brumm J, Griffin R, Gerber C. Rubino DM, et al. Among authors: stefanski a. Diabetes Obes Metab. 2025 Jan 9. doi: 10.1111/dom.16176. Online ahead of print. Diabetes Obes Metab. 2025. PMID: 39789843

9

Tirzepatide for Obesity Treatment and Diabetes Prevention.

Jastreboff AM, le Roux CW, Stefanski A, Aronne LJ, Halpern B, Wharton S, Wilding JPH, Perreault L, Zhang S, Battula R, Bunck MC, Ahmad NN, Jouravskaya I; SURMOUNT-1 Investigators. Jastreboff AM, et al. Among authors: stefanski a. N Engl J Med. 2024 Nov 13. doi: 10.1056/NEJMoa2410819. Online ahead of print. N Engl J Med. 2024. PMID: 39536238

10

Association between weight reduction achieved with tirzepatide and quality of life in adults with obesity: Results from the SURMOUNT-1 study.

Gudzune KA, Stefanski A, Cao D, Mojdami D, Wang F, Ahmad N, Ling Poon J. Gudzune KA, et al. Among authors: stefanski a. Diabetes Obes Metab. 2025 Feb;27(2):539-550. doi: 10.1111/dom.16046. Epub 2024 Nov 4. Diabetes Obes Metab. 2025. PMID: 39497468 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters